Who is sponsoring NCT04014816?

NCT04014816 is sponsored by Ayancık State Hospital.

What drugs are being tested in NCT04014816?

Interventions in NCT04014816: MDR bacteria positivity, negative fluid balance.

What condition does NCT04014816 study?

NCT04014816 studies Gastrointestinal Disease, Constipation, Intolerance; Nutritional, Diarrhea.

Is NCT04014816 still recruiting?

NCT04014816 is currently completed. Last updated 10 July 2019.

Last reviewed 2019-07-10 · How we verify

NCT04014816

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill Patients

Completed Last updated 10 July 2019

What this trial tests

trial testing MDR bacteria positivity in Gastrointestinal Disease in 137 participants. Completed in 1 July 2015.

Timeline

1 January 2015

Primary endpoint
1 July 2015

1 July 2015

Quick facts

Lead sponsor	Ayancık State Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	137
Start date	1 January 2015
Primary completion	1 July 2015
Estimated completion	1 July 2015

Drugs / interventions tested

MDR bacteria positivity
negative fluid balance

Conditions studied

Gastrointestinal Disease — all drugs for Gastrointestinal Disease →
Constipation — all drugs for Constipation →
Intolerance; Nutritional — all drugs for Intolerance; Nutritional →
Diarrhea — all drugs for Diarrhea →

Sponsor

Ayancık State Hospital

Who can join

18 and older, any sex, with Gastrointestinal Disease or Constipation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastrointestinal (GI) motility disorders in intensive care patients remain relatively unexplored. Nowadays, the frequency, risk factors and complications of GI dysfunction during enteral nutrition (EN) become more questionable. Our aim is to evaluate the frequency, risk factors and complications of GI dysfunction during EN in the first 2 weeks of the intensive care unit (ICU) stay and to identify precautions to prevent the development of GI dysfunction and avoid complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gastrointestinal Disease

Currently open trials in the same condition.

NCT05053191 — Advancing Nursing Practices in Hospital Oncology Care · NA · active not recruiting
NCT04949282 — Spanish Series of Patients Treated With the Radionuclide Lutetium177 · recruiting
NCT03566160 — Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy · NA · active not recruiting

Other Ayancık State Hospital trials

Trials by the same sponsor.

NCT03911648 — Analgesic Efficacy of Lidocaine Plus Bupivacaine Versus Bupivacaine Alone Caudally · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04014816 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ayancık State Hospital
Last refreshed: 10 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04014816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing